HIV - See a pocket, block it

被引:7
作者
Moore, JP [1 ]
Dragic, T [1 ]
机构
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA
关键词
D O I
10.1038/44504
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The focus of drugs for treating HIV-1 infection has switched from protease and reverse-transcriptase inhibitors to compounds that prevent fusion of the virus with human cells. The target protein in this pathway is known as gp41, and, last year, a pocket was identified in gp41 that could act as the binding site for a fusion inhibitor. Peptide inhibitors that specifically bind this pocket have now been identified.
引用
收藏
页码:759 / 759
页数:1
相关论文
共 13 条
[1]   Core structure of gp41 from the HIV envelope glycoprotein [J].
Chan, DC ;
Fass, D ;
Berger, JM ;
Kim, PS .
CELL, 1997, 89 (02) :263-273
[2]   Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target [J].
Chan, DC ;
Chutkowski, CT ;
Kim, PS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15613-15617
[3]   Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket [J].
Eckert, DM ;
Malashkevich, VN ;
Hong, LH ;
Carr, PA ;
Kim, PS .
CELL, 1999, 99 (01) :103-115
[4]   Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [J].
Finzi, D ;
Blankson, J ;
Siliciano, JD ;
Margolick, JB ;
Chadwick, K ;
Pierson, T ;
Smith, K ;
Lisziewicz, J ;
Lori, F ;
Flexner, C ;
Quinn, TC ;
Chaisson, RE ;
Rosenberg, E ;
Walker, B ;
Gange, S ;
Gallant, J ;
Siliciano, RF .
NATURE MEDICINE, 1999, 5 (05) :512-517
[5]   Capture of an early fusion-active conformation of HIV-1 gp41 [J].
Furuta, RA ;
Wild, CT ;
Weng, YK ;
Weiss, CD .
NATURE STRUCTURAL BIOLOGY, 1998, 5 (04) :276-279
[6]   HIV-1 INHIBITION BY A PEPTIDE [J].
JIANG, SB ;
LIN, K ;
STRICK, N ;
NEURATH, AR .
NATURE, 1993, 365 (6442) :113-113
[7]   Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors [J].
Jones, PLS ;
Korte, T ;
Blumenthal, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :404-409
[8]   Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry [J].
Kilby, JM ;
Hopkins, S ;
Venetta, TM ;
DiMassimo, B ;
Cloud, GA ;
Lee, JY ;
Alldredge, L ;
Hunter, E ;
Lambert, D ;
Bolognesi, D ;
Mathews, T ;
Johnson, MR ;
Nowak, MA ;
Shaw, GM ;
Saag, MS .
NATURE MEDICINE, 1998, 4 (11) :1302-1307
[9]   Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions [J].
Lucas, GM ;
Chaisson, RE ;
Moore, RD .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (02) :81-+
[10]   HIV-1 entry inhibitors: Evading the issue [J].
Michael, NL ;
Moore, JP .
NATURE MEDICINE, 1999, 5 (07) :740-742